| 0 (0%) | 09-08 12:47 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 53.58 | 1-year : | 62.59 |
| Resists | First : | 45.88 | Second : | 53.58 |
| Pivot price | 43.84  |
|||
| Supports | First : | 38.88 |
Second : | 34.56 |
| MAs | MA(5) : | 44.16 |
MA(20) : | 42.53 |
| MA(100) : | 33.34 |
MA(250) : | 0 | |
| MACD | MACD : | 2 |
Signal : | 2.4 |
| %K %D | K(14,3) : | 59.6 |
D(3) : | 82.5 |
| RSI | RSI(14): 48.7 |
|||
| 52-week | High : | 45.88 | Low : | 25.17 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ TBXU ] has closed below the lower bollinger band by 8.4%. Bollinger Bands are 2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 44.9 - 45.14 | 45.14 - 45.34 |
| Low: | 43.78 - 44.09 | 44.09 - 44.35 |
| Close: | 43.92 - 44.39 | 44.39 - 44.78 |
Thu, 18 Jun 2026
TBXU - Direxion Daily Biotech Top 5 Bull 2X ETF Latest SEC Filings - Finviz
Wed, 01 Oct 2025
TBXU ETF Price and Chart — AMEX:TBXU - tradingview.com
Wed, 01 Oct 2025
Trade Top 5 Industry Leaders With Direxion's New Titans ETFs - ETF Trends
Tue, 30 Sep 2025
TBXU: Biotech Top 5 Bull 2X ETF - direxion.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|